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Abstract 
 
Background/Aim. Diabetic foot is the term for the 
pathological changes on foot in patients with diabetes. It is 
caused by diabetic angiopathy, polyneuropathy and 
osteoarthropathy. The treatment is complex and long-term 
and often leads to the loss of the extremity. The appliance 
of hyperbaric oxygen therapy (HBOT) has a lot more 
important place in adjuvant treatment of this disease. The 
aim of this study was to determine the influence of HBOT 
on the wound healing in comparison with the conventional 
treatment, the possibility of shortening the time of the 
treatment in patients with diabetic foot. Methods. In a five-
year period a retrospective-prospective multicentric study, 
involving 60 patients with diabetic foot divided into two 
groups, was performed. The first group (group A) consisted 
of 30 patients treated by combined therapy (with medica-
tions, surgical therapy and HBOT). All the patients were 
receiving HBOT in the Special Hospital for Hyperbaric 
Medicine, CHM Hollywell-Neopren in Belgrade. The con-
trol group (group B) also consisted of 30 patients treated 
with medications and surgical therapy, but without HBOT. 
Results. The demographic data, the types of diabetes, as 
well as the Wagner classification stage of diabetic ulcers and 
radiography scans of changes in bones were equal in both 
groups. The median healing time of the Wagner grade III 
ulcer in the group A was 37.36 days [mean ± standard 
deviation (SD) = 65.6 ± 45.8 days], and in the group B 
99.78 days (mean ± SD = 134.8 ± 105.96 days) and it was 
statistically significant (p = 0.074). The median time of 
recovery in patients of the group A with the Wagner grade 
IV was 48.18 days (mean ± SD = 49.7 ± 33.8 days), and in 
the group B 85.05 days (mean ± SD = 86.7 ± 71.6 days) 
and that was statistically significant (p = 0.121). The foot 
amputations were performed in both groups in 3 (10%) 
patients. In the group A there were no high amputations, 
whereas in the group B there were 4 (13.33%) below-knee 
amputations and 4 (13.33%) above-knee amputations which 
was highly statistically significant (p < 0.0001). Conclusion. 
In this study, HBOT definitely showed positive adjuvant 
role in the treatment of diabetic foot. For the good treat-
ment result it is essential the timely and successful surgical 
treatment of the ulcer and the use of bandage with the 
healing dressings. In case of the clear signs of local infec-
tion, the antibiotic therapy according to the antibiogram is 
necessary. 
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Apstrakt 
 
Uvod/Cilj. Dijabetičnim stopalom nazivamo patološke 
promene na stopalu kod bolesnika koji boluju od šećerne 
bolesti, a uzrokovane su dijabetičkom angiopatijom, poli-
neuropatijom i osteoartropatijom. Lečenje je kompleksno i 
dugotrajno i često dovodi do gubitka esktremiteta. Primena 
hiperbarične oksigene terapije (HBOT) ima sve značajnije 
mesto u adjuvantnom lečenju ovog oboljenja. Cilj ovog rada 
bio je utvrđivanje uticaja HBOT na efikasnije zarastanje 
rane u poređenju sa konvencionalnim lečenjem i mogućnost 
skraćenja vremena lečenja bolesnika sa dijabetičkim stopa-
lom. Metode. U petogodišnjem periodu urađena je retro-
spektivno-prospektivna multicentrična studija, koja je 
obuhvatila 60 bolesnika podeljenih u dve grupe. Prva grupa 
(grupa A) od 30 bolesnika lečena je kombinovanom terapi-
jom (medikamentoznom, hirurškom i HBOT). Svi bolesnici 
dobijali su HBOT u Specijalnoj bolnici za hiperbaričnu 
medicinu, CHM Hollywell-Neopren u Beogradu. Kontrolna 
grupa (grupa B), takođe od 30 bolesnika sa dijabetičkim 
stopalom, lečena je medikamentozno i hirurški, ali bez 
HBOT. Rezultati. Demografski podaci, tip dijabetesa, 
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stadijum dijabetičkih rana prema Wagner-u i nalazi radio-
grafskih promena na kostima bili su jednaki u obe grupe. 
Medijana vremena za sanaciju rane III stadijuma po 
Wagner-u u grupi A iznosila je 37,36 dana [srednja vrednost 
± standardna devijacija (SD) = 65,6 ± 45,8 dana], a u grupi 
B 99,78 dana (srednja vrednost ± SD = 134,8 ± 105,96 
dana) (p = 0,074). Bolesnici u IV stadijumu po Wagner-u u 
grupi A imali su medijanu vremena za sanaciju rane od 
48,18 dana (srednja vrednost ± SD = 49,7 ± 33,8 dana), a u 
grupi B 85,05 (srednja vrednost ± SD =86,7 ± 71,6 dana) 
(p = 0,121). Amputacije stopala bile su izvršene u obe grupe 
kod tri (10%) bolesnika. U grupi A nije bilo ni jedne visoke 
amputacije, a u grupi B su bile izvršene četiri (13,33%)  
potkolene i četiri (13,33%) natkolene amputacije, što je bilo 
visoko statistički značajno (p < 0,0001). Zaključak. HBOT 
u ovoj studiji kao i kod većine drugih autora definitivno je 
pokazala pozitivnu adjuvantnu ulogu u lečenju dijabetičkog 
stopala. Za dobar rezultat lečenja potrebna je pravovremena 
i sukcesivna hirurška obrada rane i zavoj lekovitim obloga-
ma. U slučaju pojave jasnih znakova lokalne infekcije po-
trebna je antibiotska terapija prema antibiogramu. 
 
Ključne reči: 
dijabetesno stopalo; hiperbarična oksigenacija; 
amputacija; rana, zarastanje. 
 
Introduction 
Diabetic foot is the term for the pathological changes on 
foot caused by ischaemia as a consequence of micro-
angiopathy, the late notice of soft tissue damage and slow 
ulcer healing as a result of polyneuropathy as well as the 
uneven pressure of footwear due to the deformation of foot 
because of diabetic osteoarthropathy 1, 2. The curing demands 
a complex multimodal treatment, including regulation of 
glycaemia, antibiotic therapy, local treatment of the ulcer, as 
well as surgical or endovascular revascularization in patients 
with macro-occlusive artery disease. The healing of diabetic 
foot ulcer is longterm and in 60% of patients it lasts about 
one year. All this is accompanied by high treatment costs and 
additional social problems 3. In the most of European 
countries 10% of health care costs are expended on diabetes 
treatment, and 68% of those are spent on the curing the 
disease complications. 
In the newer literature hyperbaric oxygen therapy 
(HBOT) has a lot more significant place in an adjuvant 
treatment of this disease 4. HBOT means a breathing 100% 
oxygen in a special chamber, in higher ambient pressure 
conditions (2.0–2.9 Kpa), determined by the particular 
protocols. The oxygen content in plasma increases from 0.3 
to 5.62 volume percents. The average number of treatments 
is 20 (from 15 to 30). In normal conditions haemoglobin-
bound oxygen is transported to the cells in erythrocytes. In 
the hyperbaric pressure conditions, according to the laws of 
physics, there is the increased dissolution of molecular 
oxygen in plasma which enables the oxygen supply even 
there where the blood vessels are narrowed (the capillary 
lumen is smaller than the erythrocytes’ diameter) or occlu-
sive 5, 6. In patients with diabetic foot HBOT ameliorates the 
peripheral tissue oxygen supply, and in addition to that 
oxygen has antibacterial (for anaerobic flora it is bacte-
ricidal), anti-inflamatory and imunosuppressive effects 7, 8. 
These effects are made by the inhibition of prostaglandins, 
interfereon gamma (IFNG), interleukin-1 and interleukin-2 9. 
The hyperbaric oxygenation is beneficial for wound healing 
due to stimulation of fibroblast proliferation and differen-
tiation, and rapid collagen synthesis 10, 11. The neovascu-
larization is stimulated and the energy metabolism of 
peripheral cells is increased. 
The aim of this study was to determine the significance 
of HBOT as an adjuvant therapy that may influence on: the 
efficient healing of diabetic foot ulcer in comparison to the 
conventional type of treatment (with medications and 
surgical treatment); the possibility of shortening the time of 
diabetic foot healing and reducing the treatment costs in 
patients with diabetic foot. 
Methods 
In a five-year period a retrospective-prospective multi-
centric study was conducted which involved 60 patients 
divided into two groups. The first group (group A), consisted 
of 30 patients, was treated by combined therapy (with 
medications, surgical therapy and HBOT). There were 25 
patients from the Clinic for Surgery “Zvezdara” in Belgrade 
and the rest 5 of them were from The Clinic for the Vascular 
and Endovascular Surgery, Clinical Center of Serbia, 
Belgrade. All the patients were receiving HBOT in Special 
Hospital for Hyperbaric Medicine, CHM Hollywell-Neopren 
in Belgrade. 
The control group (group B), also consisted of 30 
patients, was treated with medications and surgical therapy, 
but without HBOT. Twenty three patients were treated in the 
Clinic for Surgery “Zvezdara” in Belgrade and the remaining 
7 patients in the Clinic for the Vascular and Endovascular 
Surgery, Clinical Center of Serbia, Belgrade. 
Only the patients with diabetic foot in whom magistral 
arteries were passable and surgical or endovascular revas-
cularization was not indicated, as proved by non-invasive 
examination (Color duplex sonography – CDS, Ankle 
brachial index – ABI), were included in the study. Before the 
treatment, radiography scans were made to all the patients 
and the wound smear was taken for the bacteriological exa-
mination. 
The inclusion criteria for the study were: palpable pedal 
pulses; an ancle-brachial index (ABI) higher than 0.75; 
three-phase spectrogram on pedal arteries. 
The surgical interventions were performed in both 
groups depending on the type of diabetic foot lesions and 
with: ulcers – necrectomia; phlegmons – incision, contra-
incision, drainage; osteomyelitis – incision, contra-incision, 
sequestrectomia; gangrene – necrectomia or amputation. 
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The transplantation of skin (Thiersch) was performed in 
a few patients with the amputation of foot in the joint line 
(Chopart or Lisfranc) in order to shorten the healing period. 
The complete recovery considered the state of full 
epithelialization of the wound or recovery of inflammatory 
changes (the soft tissue and the bone). In patients with the 
amputation the recovery considered the full healing of the 
amputation stump. 
Statistical analysis 
Descriptive statistics were used for the processing 
demographic and clinical characteristics of patients in both 
groups. Categorical variables were compared by using χ2 
test. Continuous variables were compared by ANOVA test, 
or Median test (for variables without normal distribution). A 
significance of 0.05 was required. Means ± standard devia-
tions (SD) and medians with the corresponding 95% 
confidence intervals (CI) were estimated. Analyses were 
performed using SPSS for Windows, Version 22 (SPSS, Inc., 
Chicago, IL). 
Results 
Patients characteristics in both groups are presented in 
Tables 1 and 2. 
The Group A was treated by combined therapy (with 
medications, surgical therapy and HBOT), and the Group B 
was treated in the same way, but without HBOT. It was 
shown that there were no statistically significant differences 
in demographic data between patients in the Groups A and B 
(Table 3). 
In the group A there were 11 patients with type 1 
diabetes and 19 with type 2 diabetes. In the control group 
there were 12 patients with type 1 diabetes and 18 with type 
2 diabetes. There was no statistically significant difference 
between groups regarding diabetes type. Among 30 patients 
in the group A, 12 were with the Wagner grade III ulcers and 
18 with the Wagner grade IV ulcers. In the control group 
(group B) there were 10 patients with ulcers of the grade III 
in the Wagner classification system, and 20 with the Wagner 
grade IV ulcers (Table 3). 
Based on the foot radiography, the patients were 
divided into subgroups with osteoporosis, osteoarthropathy, 
osteomyelitis and the normal finding of foot bones. In the 
group A the normal result was found in 50% of the patients, 
and in the group B in 60% of the patients (Table 3). 
The most frequent pathological result was osteomye-
litis, which was diagnosed in 30% of the patients in the 
group A and in 26.67% of the patients in the group B. 
Radiography results of foot bones did not differ significantly 
between groups. 
The type of surgical intervention depended on the local 
result (Table 3). Incision and drainage were performed in 5 
patients in total, in the group A in 3 (10%) patients, whereas 
in the group B in 2 (6.7%) patients. 
Necrectomia was the most frequent intervention in the 
group A (in 17 patients or 56.7%) while in the group B just 
in 3 (10%) patients. The finger amputations were conducted 
in 7 (23.3%) patients of the group A and in 14 (46.7%) 
patients of the group B. The foot amputations (transme-
tatarsal, in Chopart and Lisfranc’s joint line) were performed 
in 3 (10%) patients in each the group. There were no high 
amputations in the group A, but there were 4 (13.3%) below-
knee and 4 (13.3%) above-knee amputations in the group B 
(p < 0.0001). 
In this study the mean (± SD) healing time of the Wagner 
grade III ulcer in the group A was 65.6 (± 45.8) days whereas in 
the group B it was 134.8 (± 105.96) days (p = 0.074). 
In the group A, the patients with the Wagner grade IV 
ulcers had the mean time of healing 49.7 (± 33.8) days, and 
in the group B 86.7 (± 71.6) days (p = 0.121) (Tables 4). 
The first control examination was carried out immediately 
after the healing process was finished, the second one was after 
a month and later on, the examinations were carried out in three 
months. In case of deterioration of the local result the 
examinations were carried out more frequently. 
In patients treated with HBOT the most common side 
effects were discomfort and ear pain (17–20%) and claustro-
phobia (13%). The cases of pneumothorax and neurological 
disturbances were not noticed. 
Ten patients from the group A had some problems after 
healing of diabetic foot lesions: one patient – foot pain and 
discomfort during walking; five patients – ulcer appearing at 
the different place on the same foot, or ulcer appearing on 
the other foot; four patients – foot deformation after the 
surgical interventions and discomfort during walking; four 
patients died within a year; 7 patients did not come for the 
control examination and their state was not known. 
Discussion 
The reasons for the bad outcomes of the diabetic foot 
ulcer healing are combined influences of ischaemia with 
hypoxia of soft tissues, prolonged wound healing due to 
existing polyneuropathy and propensity to infection 12. Many 
authors report about positive influence of oxygen therapy in 
hyperbaric conditions on the healing or reducing the major 
complications of diabetic foot ulcer. In this study the effects 
of treatments on the Wagner grades 3 and 4 ulcers in two 
groups of patients with diabetic foot were compared 13. The 
first group of 30 patients was treated with HBOT and 
medication and surgical methods (group A), whereas the the 
control group (group B) was treated with medication and 
surgical methods in the same way, but without HBOT. 
In regards to significant parameters, this study showed the 
positive influence of HBOT on diabetic foot ulcer healing, 
especially in regard to the most important result – high 
amputation. Moreover, there were no above-knee and below-
knee amputations whereas there were 8 amputations in the 
control group and that was highly significant (p < 0.0001). 
The most patients in the group A well tolerated HBOT. 
The most common side effects were discomfort and ear pain 
(17–20%) and after that claustrophobia (13%). The cases of 
pneumothorax and neurological disturbances were not 
noticed. 
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Table 3 
Summary of patients demographic characteristics, diabetes mellitus (DM) type and the ulcer grade (Wagner 
classification) 
Characteristics 
 
Group A 
 
 
Group B 
 
p 
Number of patients 30 30  
Age (years), mean ± SD  
      median 
62.67 ± 10.71 
64.5 
64.20 ± 11.35 
65.5 
0.592 
      range 30–80 37–83  
Gender, n (%)    
     female 7 (23) 8 (27) 0.766 
     male 23 (77) 22 (73)  
Type of DM, n (%) 
      I 
      II 
 
11 (37) 
19 (63) 
 
12 (40) 
18 (60) 
 
0.791 
Wagner classification, n (%) 
      3 
      4 
 
12 (40) 
18 (60) 
 
10 (33.3) 
20 (66.7) 
 
0.592 
Radiographic findings, n (%)    
     without pathological result  
     osteoarthropathy 
     osteomyelitis 
     osteoporosis 
15 (50.0) 
1 (3.3) 
9 (30.0) 
5 (16.7) 
18 (60.0) 
3 (10.0) 
8 (26.7) 
1 (3.3) 
0.262 
Intervention type, n (%) 
     incision 
     necrectomia 
     finger amputation 
     foot amputation 
     high amputation 
 
3 (10.0) 
17 (56.7) 
7 (23.3) 
3 (10.0) 
0 (0.0) 
 
2 (6.7) 
3 (10.0) 
14 (46.7) 
3 (10.0) 
8 (26.7) 
0.0001 
Group A – patients treated by combination of conventional therapy + hyperbaric oxygen therapy (HBOT); 
Group B – patients treated by conventional therapy only; SD – standard deviation. 
 
Table 4 
Treatment period before entering the study and the healing period in patients with diabetic foot  
95% CI Treatment period 
 (days) 
n Mean ± SD lower  
bound 
upper  
bound 
Min. Max. 
Group A    
Wagner 3 12 26.2 ± 31.7 6.0 46.3 7.0 120.0 
Wagner 4 18 39.5 ± 54.0 12.7 66.3 3.0 180.0 
   before entering the study 
Total  30 34.2 ± 46.2 16.9 51.4 3.0 180.0 
Wagner 3 12 65.6 ± 45.8 36.5 94.7 20.0 150.0 
Wagner 4 18 49.7 ± 33.8 32.8 66.5 15.0 130.0 
        healing period 
Total  30 56.0 ± 39.1 41.4 70.6 15.0 150.0 
Group B         
Wagner 3 10 94.6 ± 222.4 -64.5 253.7 7.0 720.0 
Wagner 4  20 54.5 ± 80.1 17.0 92.0 7.0 360.0 
     before entering the  
     study   
Total  30 67.9 ± 141.2 15.2 120.6 7.0 720.0 
Wagner 3 10 134.8 ± 106.0 59.0 210.6 28.0 360.0 
Wagner 4 20 86.7 ± 71.6 53.2 120.2 15.0 240.0 
     healing period  
Total  30 102.7 ± 85.9 70.7 134.8 15.0 360.0 
SD – standard deviation; CI - confidence interval. 
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Baroni et al. 14 were among the first who published 
treatment outcomes with HBOT. In their study, when compa-
ring the two groups of patients (the group treated with HBOT 
and the group without receiving HBOT) the statistical 
analysis using χ2 test demonstrated highly significant diffe-
rence (p = 0.001) in favour of HBOT. In regards to the most 
significant parameter, the limb amputation, HBOT drasti-
cally reduced the percentage of amputations. These results 
coincide with our experience. 
Kalani et al. 15 from Karolinska Hospital, Stockholm, 
Sweden, in their study followed-up the treatment results of two 
groups of patients with diabetic foot (treated with and without 
HBOT) during 3 years. Seventy six percent of patients treated 
with HBOT had healed ulcer lesion and intact skin, whereas in 
the group of patients treated conventionally that effect was 
obtaind in 48% of the patients. The amputation had to be 
performed just in 12% of the patients in the HBOT group and in 
33% of the conventionally treated patients 15. 
The mechanisms by which HBOT acts positively on 
diabetic foot ulcer healing are the reducing of wound exudate 
and stimulation of granulation process. The values of partial 
oxygen pressure in the wound surrounding during HBOT 
may indicate the future treatment outcome. There is positive 
correlation between transcutanous oxygen pressure (TcPO2) 
values and the speed of the wound size and exudate reduc-
tion, and epithelialization 16. A negative correlation between 
TcPO2 values and parameters of wound healing was de-
termined in the group of patients whose treatment ended with 
high amputations 17. 
The authors who have compared the patients with the 
Wagner grades III and IV diabetic foot ulcer conclude that 
HBOT after 30 sessions greatly contributes to prevention of 
amputations and the healing of the wound by epithelialization, 
but an antibiotic therapy has alsorole in the healing process 18. 
In comparison with the results of Fedorko et al. 19 who 
randomly chosen 103 patients divided into two groups (49 in the 
HBOT group and 54 in the control group), our results are far 
better regarding amputations. They had 22.4% of high 
amputations in each group. In HBOT group 11 out of 49, and in 
the control group 13 out of 54 patients with the Wagner grades 
III and IV diabetic foot ulcer had underwent amputations. 
Conclusion 
HBOT definitely has positive adjuvant role in managing 
diabetic foot. For the optimal treatment results successful 
surgical ulcer treatment is necessary and the use of bandage 
with the healing dressings, as well as the treatment with 
HBOT. In case of the clear signs of local infection, antibiotic 
therapy according to the antibiogram is necessary. 
The medical practitioners, the patients and policy 
creators should define good clinical practice guidelines of 
Shared Decision Making for appliance of hyperbaric oxygen 
therapy as the additional treatment for diabetic foot 
management. The future researches should be aimed at the 
improvement of methods for choosing patients, testing 
various protocols of treatment and improvement of trust in 
those assessments. The routine implementation of 
transcutaneous oximetry imposes itself as a simple, cheap 
and reliable method for early assessment of HBOT efficacy 
and the patients are not needlessly exposed to the efforts 
which exist at some degree (arrival from their home to 
Centre for baromedicine or organizing transport from their 
hospital to the Centre). The special problem is the treatment 
cost which should be paid by the Health Insurance Fund 
without interference with ethical principles that every patient 
should have the same right on treatment if that treatment is a 
proper one. 
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